Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumors

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Chosdol, Kunzang ^a   Misra, Anjan ^a,b   Puri, Sachin ^a,c   Srivastava, Tapasya ^a   Chattopadhyay, Parthaprasad ^a   Sarkar, Chitra ^a   Mahapatra, Ashok K ^a,d   Sinha, Subrata ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

^d SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN FAT; UNCLASSIFIED DRUG; CADHERIN; FAT PROTEIN, HUMAN; PRIMER DNA;

ARTICLE; ASTROCYTIC TUMOR; CARCINOGENESIS; DNA FINGERPRINTING; DROSOPHILA; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INSERTION; GENE LOCUS; GENE REPRESSION; GENE SEQUENCE; GENETIC IDENTIFICATION; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROMOTER REGION; RANDOM AMPLIFIED MICROSATELLITE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; ASTROCYTOMA; BINDING SITE; CENTRAL NERVOUS SYSTEM TUMOR; GENETICS; METHODOLOGY; PATHOLOGY; RANDOM AMPLIFIED POLYMORPHIC DNA;

ASTROCYTOMA; BINDING SITES; CADHERINS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DNA FINGERPRINTING; DNA PRIMERS; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; LOSS OF HETEROZYGOSITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 59249096379     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-5     Document Type: Article

References (45)

1. Louis DN Ohgaki H Wiestler OD Cavenee WK Burger PC Jouvet A Scheithauer BW Kleihues P The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 2007, 114:97-109 1929165 17618441 10.1007/s00401-007-0243-4
2. von Deimling A von Ammon K Schoenfeld D Wiestler OD Seizinger BR Louis DN Subsets of glioblastoma multiforme defined by molecular genetic analysis Brain Pathol 1993, 3:19-26. 10.1111/j.1750-3639.1993.tb00721.x 8269081
3. James CD Mikkelsen T Cavenee WK Collins VP Molecular genetic aspects of glial tumour evolution Cancer Surv 1990, 9:631-644. 1983210
4. Kleihues P Cavenee WK Tumours of the Nervous System: Pathology and Genetics Lyon, France: IARC press 2; 2000.
5. Hill JR Kuriyama N Kuriyama H Israel MA Molecular genetics of brain tumors Arch Neurol 1999, 56:439-441. 10.1001/archneur.56.4.439 10199332
6. Ware ML Berger MS Binder DK Molecular biology of glioma tumorigenesis Histol Histopathol 2003, 18:207-216. 12507300
7. Sanson M Thillet J Hoang-Xuan K Molecular changes in gliomas Curr Opin Oncol 2004, 16:607-613. 10.1097/01.cco.0000142485.81849.cc 15627025
8. Williams JG Kubelik AR Livak KJ Rafalski JA Tingey SV DNA polymorphisms amplified by arbitrary primers are useful as genetic markers Nucleic Acids Res 1990, 18:6531-6535. 332606 1979162 10.1093/nar/18.22.6531
9. Joshi AR Sinha S Dil A Sulaiman IM Banerji AK Hasnain SE Alterations in brain tumor DNA detected by a fingerprinting probe Indian J Biochem Biophys 1996, 33:455-457. 9219429
10. Dil A Misra A Sulaiman IM Sinha S Sarkar C Mahapatra AK Hasnain SE Genetic alterations in brain tumors identified by RAPD analysis Gene 1998, 206:45-48. 10.1016/S0378-1119(97)00579-9 9461413
11. Misra A Chattopadhyay P Dinda AK Sarkar C Mahapatra AK Hasnain SE Sinha S Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations J Neurooncol 2000, 48:1-12. 10.1023/A:1006435201961 11026691
12. Jotwani G Misra A Chattopadhyay P Sarkar C Mahapatra AK Sinha S Genetic heterogeneity and alterations in chromosome 9 loci in a localized region of a functional pituitary adenoma Cancer Genet Cytogenet 2001, 125:41-45. 10.1016/S0165-4608(00)00356-3 11297766
13. Misra A Chattopadhyay P Chosdol K Sarkar C Mahapatra AK Sinha S Clonal mutations in primary human glial tumors: Evidence in support of the mutator hypothesis BMC Cancer 2007, 7:190. 2190769 17925012 10.1186/ 1471-2407-7-190
14. Misra A Chosdol K Sarkar C Mahapatra AK Sinha S Alteration of a sequence with homology to human endogenous retrovirus (HERV-K) in primary human glioma: Implications for viral repeat mediated rearrangement Mutat Res 2001, 484:53-59. 11733071
15. Srivastava T Seth A Datta K Chosdol K Chattopadhyay P Sinha S Inter-alu PCR detects high frequency of genetic alterations in glioma cells exposed to sub-lethal cisplatin Int J Cancer 2005, 117:683-689. 10.1002/ ijc.21057 15912534
16. Srivastava T Chosdol K Chattopadhayay P Sarkar C Mahapatra AK Sinha S Frequent loss of heterozygosity encompassing the hMLH1 locus in low grade astrocytic tumors J Neurooncol 2007, 81:249-255. 10.1007/ s11060-006-9230-1 17019533
17. Puri S Joshi BH Sarkar C Mahapatra AK Hussain E Sinha S Expression and structure of interleukin 4 receptors in primary meningeal tumors Cancer 2005, 103:2132-2142. 10.1002/cncr.21008 15830341
18. McClelland M Mathieu-Daude F Welsh J RNA fingerprinting and differential display using arbitrarily primed PCR Trends Genet 1995, 11:242-246. 10.1016/S0168-9525(00)89058-7 7543710
19. Micheli MR Bova R Calissano P D'Ambrosio E Randomly amplified polymorphic DNA fingerprinting using combinations of oligonucleotide primers Biotechniques 1993, 15:388-390. 8105827
20. Papadopoulos S Benter T Anastassiou G Pape M Gerhard S Bornfeld N Ludwig WD Dorken B Assessment of genomic instability in breast cancer and uveal melanoma by random amplified polymorphic DNA analysis Int J Cancer 2002, 99:193-200. 10.1002/ijc.10297 11979433
21. Xian ZH Cong WM Zhang SH Wu MC Genetic alterations of hepatocellular carcinoma by random amplified polymorphic DNA analysis and cloning sequencing of tumor differential DNA fragment World J Gastroenterol 2005, 11:4102-4107. 15996039
22. Garnis C Coe BP Ishkanian A Zhang L Rosin MP Lam WL Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer Genes Chromosomes Cancer 2004, 39:93-98. 10.1002/gcc.10294 14603447
23. Schweder ME Shatters RG Jr West SH Smith RL Effect of transition interval between melting and annealing temperatures on RAPD analyses Biotechniques 1995, 19(1):38-40-2. 7669294
24. Hata N Yoshimoto K Yokoyama N Mizoguchi M Shono T Guan Y Tahira T Kukita Y Higasa K Nagata S Iwaki T Sasaki T Hayashi K Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis Clin Chem 2006, 52:370-378. 10.1373/ clinchem.2005.060954 16397012
25. Malmer B Feychting M Lonn S Ahlbom A Henriksson R p53 Genotypes and risk of glioma and meningioma Cancer Epidemiol Biomarkers Prev 2005, 14:2220-2223. 10.1158/1055-9965.EPI-05-0234 16172235
26. Hu J Jiang C Ng HK Pang JC Tong CY Chromosome 14q may harbor multiple tumor suppressor genes in primary glioblastoma multiforme Chin Med J (Engl) 2002, 115:1201-1204. 12215292
27. Cho ES Chang J Chung KY Shin DH Kim YS Kim SK Identification of tumor suppressor loci on the long arm of chromosome 4 in primary small cell lung cancers Yonsei Med J 2002, 43:145-151. 11971207
28. Zhang SH Cong WM Xian ZH Wu MC Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China World J Gastroenterol 2005, 11:3034-3039. 15918185
29. Backsch C Rudolph B Kuhne-Heid R Kalscheuer V Bartsch O Jansen L Beer K Meyer B Schneider A Durst M A region on human chromosome 4 (q35.1→qter) induces senescence in cell hybrids and is involved in cervical carcinogenesis Genes Chromosomes Cancer 2005, 43:260-272. 10.1002/gcc.20192 15838843
30. Chang J Kim NG Piao Z Park C Park KS Paik YK Lee WJ Kim BR Kim H Assessment of chromosomal losses and gains in hepatocellular carcinoma Cancer Lett 2002, 182:193-202. 10.1016/S0304-3835(02)00083-6 12048165
31. Nakaya K Yamagata HD Arita N Nakashiro KI Nose M Miki T Hamakawa H Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array Oncogene; 2007. 17325662
32. Bryant PJ Huettner B Held LI Jr Ryerse J Szidonya J Mutations at the fat locus interfere with cell proliferation control and epithelial morphogenesis in Drosophila Dev Biol 1988, 129:541-554. 10.1016/ 0012-1606(88)90399-5 3417051
33. Dunne J Hanby AM Poulsom R Jones TA Sheer D Chin WG Da SM Zhao Q Beverley PC Owen MJ Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule Genomics 1995, 30:207-223. 10.1006/geno.1995.9884 8586420
34. Ponassi M Jacques TS Ciani L ffrench Constant C Expression of the rat homologue of the Drosophila fat tumour suppressor gene Mech Dev 1999, 80:207-212. 10.1016/S0925-4773(98)00217-2 10072790
35. Cox B Hadjantonakis AK Collins JE Magee AI Cloning and expression throughout mouse development of mfat1, a homologue of the Drosophila tumour suppressor gene fat Dev Dyn 2000, 217:233-240. 10.1002/ (SICI)1097-0177(200003)217:3<233::AID-DVDY1>3.0.CO;2-O 10741417
36. Down M Power M Smith SI Ralston K Spanevello M Burns GF Boyd AW Cloning and expression of the large zebrafish protocadherin gene, Fat Gene Expr Patterns 2005, 5:483-490. 15749076
37. Moeller MJ Soofi A Braun GS Li X Watzl C Kriz W Holzman LB Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization Embo J 2004, 23:3769-3779. 522787 15343270 10.1038/ sj.emboj.7600380
38. Tanoue T Takeichi M New insights into Fat cadherins J Cell Sci 2005, 118:2347-2353. 10.1242/jcs.02398 15923647
39. Cho E Feng Y Rauskolb C Maitra S Fehon R Irvine KD Delineation of a Fat tumor suppressor pathway Nat Genet 2006, 38:1142-1150. 10.1038/ng1887 16980976
40. Bennett FC Harvey KF Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway Curr Biol 2006, 16:2101-2110. 10.1016/j.cub.2006.09.045 17045801
41. Zhao B Wei X Li W Udan RS Yang Q Kim J Xie J Ikenoue T Yu J Li L Zheng P Ye K Chinnaiyan A Halder G Lai ZC Guan KL Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control Genes Dev 2007, 21:2747-2761. 2045129 17974916 10.1101/gad.1602907
42. Hao Y Chun A Cheung K Rashidi B Yang X Tumor suppressor LATS1 is a negative regulator of oncogene YAP J Biol Chem 2008, 283:5496-5509. 10.1074/jbc.M709037200 18158288
43. Zhang J Smolen GA Haber DA Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway Cancer Res 2008, 68:2789-2794. 10.1158/0008-5472.CAN-07-6205 18413746
44. Matallanas D Romano D Yee K Meissl K Kucerova L Piazzolla D Baccarini M Vass JK Kolch W O'Neill E RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein Mol Cell 2007, 27:962-975. 10.1016/j.molcel.2007.08.008 17889669
45. Bendavid C Pasquier L Watrin T Morcel K Lucas J Gicquel I Dubourg C Henry C David V Odent S Leveque J Pellerin I Guerrier D Phenotypic variability of a 4q34 → qter inherited deletion: MRKH syndrome in the daughter, cardiac defect and Fallopian tube cancer in the mother Eur J Med Genet 2007, 50:66-72. 10.1016/j.ejmg.2006.09.003 17081814